Eli Lilly's weight loss drugs are no longer in short supply after the FDA removed them from the shortage list. This news has led to a drop in shares for competitor Hims & Hers Health, with analysts predicting a positive impact on Eli Lilly's operations.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing